SOFIA (Bulgaria), December 4 (SeeNews) -Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its CEO Ognyan Donev acquired 1,000 shares in the company through a deal priced at 3 levs ($1.85/1.53 euro) per share on December 3.